TAKEDA PHARMACEUTICAL CO LTD
CIK 1395064 · Holdings on Sep 30, 2024 · First reported Feb 13, 2025
Top ten holdings
Q3 2024- 43157M10231.18%
- 9666679D29.10%
- OVID23.42%
- STTK4.74%
- EQ3.99%
- 98422T1003.06%
- AMWL1.94%
- 90042W1001.31%
- RANI1.16%
- LAB0.08%
Share classes counted separately99.98%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- 9666679DWeight increased · +26.21 pp2.89% → 29.10%Shares 0 (0.00%)
- OVIDWeight increased · +20.93 pp2.49% → 23.42%Shares 0 (0.00%)
- 43157M102Weight decreased · -10.67 pp41.85% → 31.18%Shares 0 (0.00%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 10
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | 43157M102HilleVax, Inc. View history and evidence | $11.83M | 31.18% | 6.72M shares | 41.85% → 31.18%-10.67 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | 9666679DWAVE LIFE SCIENCES LTDSHS View history and evidence | $11.04M | 29.10% | 1.35M shares | 2.89% → 29.10%+26.21 pp 0 (0.00%) | Unchanged | ↗▾ |
| 03 | OVIDOVID THERAPEUTICS INC View history and evidence | $8.89M | 23.42% | 7.53M shares | 2.49% → 23.42%+20.93 pp 0 (0.00%) | Unchanged | ↗▾ |
| 04 | STTKSHATTUCK LABS INC View history and evidence | $1.80M | 4.74% | 515.62K shares | 0.86% → 4.74%+3.88 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | EQEQUILLIUM INC View history and evidence | $1.51M | 3.99% | 1.82M shares | 0.54% → 3.99%+3.45 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | 98422T100Xilio Therapeutics, Inc. View history and evidence | $1.16M | 3.06% | 1.48M shares | 0.60% → 3.06%+2.46 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | AMWLAMERICAN WELL CORP-CLASS ACOM CL A NEW View history and evidence | $736.91K | 1.94% | 77.73K shares | 0.22% → 1.94%+1.72 pp -1.48M (-95.00%) | Reduced | ↗▾ |
| 08 | 90042W100Turnstone Biologics Corp. View history and evidence | $498.97K | 1.31% | 895.82K shares | 1.01% → 1.31%+0.30 pp 0 (0.00%) | Unchanged | ↗▾ |
| 09 | RANIRANI THERAPEUTICS HOLDINGS-ACOM CL A View history and evidence | $438.89K | 1.16% | 203.19K shares | 0.35% → 1.16%+0.81 pp -11.98K (-5.57%) | Reduced | ↗▾ |
| 10 | LABSTANDARD BIOTOOLS INC View history and evidence | $31.87K | 0.08% | 16.52K shares | 0.01% → 0.08%+0.07 pp 0 (0.00%) | Unchanged | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 3
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| DNLI DENALI THERAPEUTICS INC | Non-derivative | -4,214,559 | -$97.86M | SEC filing ↗ | SEC filing ↗ |
| PHAT PHATHOM PHARMACEUTICALS INC | Non-derivative | -1,557,063 | -$16.04M | SEC filing ↗ | SEC filing ↗ |
| 00974B107 Akili, Inc. | Non-derivative | -738,819 | -$321.39K | SEC filing ↗ | SEC filing ↗ |
3 / 3 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1395064 · Period 2024-09-30
Data loaded 2026-09-23 · First reported 2025-02-13
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 37950196
}Take these holdings further.
This page includes 10 of 10 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 10 of 10 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1395064","quarter":"2024Q3","page_size":100}
get_institutional_manager_history
{"cik":"1395064","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.